COI Declaration Policy in Medical Journals: From Authors to Editors
Learned Publishing · 2026-07 · 39 (3)
DOI: 10.1002/leap.2084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Learned Publishing, online erschienen am 10.07.2026. Verfasst von Lili Yang und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Key Points Medical journal editors commonly have widespread financial relationships with pharmaceutical or device companies, which may unconsciously influence the whole manuscript processing. The transparency and comprehensiveness of editor's public COI disclosure is far less sufficient. It is important to clearly and comprehensively outline the COI disclosure requirements for editors and the editorial team. It is important for medical journals to establish a mandatory interest disclosure and recusal mechanism for dealing with the situations when the editors act as the coauthors.
Zitieren
APA
Yang, L., & Shao, J. (2026). COI Declaration Policy in Medical Journals: From Authors to Editors. Learned Publishing, 39(3). https://doi.org/10.1002/leap.2084
Vancouver
Yang L, Shao J. COI Declaration Policy in Medical Journals: From Authors to Editors. Learned Publishing. 2026;39(3). doi:10.1002/leap.2084
BibTeX
@article{Yang2026,
author = {Yang, Lili and Shao, Jufang},
title = {COI Declaration Policy in Medical Journals: From Authors to Editors},
journal = {Learned Publishing},
year = {2026},
volume = {39},
number = {3},
doi = {10.1002/leap.2084}
}
EUVIMED